Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography - PubMed (original) (raw)
Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography
K V Williams et al. Diabetes. 2001 Sep.
Abstract
It has been postulated that glucose transport is the principal site of skeletal muscle insulin resistance in obesity and type 2 diabetes, though a distribution of control between glucose transport and phosphorylation has also been proposed. The current study examined whether the respective contributions of transport and phosphorylation to insulin resistance are modulated across a dose range of insulin stimulation. Rate constants for transport and phosphorylation in skeletal muscle were estimated using dynamic positron emission tomography (PET) imaging of 2-deoxy-2[18F]fluoro-D-glucose ([18F]FDG) during insulin infusions at three rates (0, 40, and 120 mU/m2 per min) in lean glucose-tolerant, obese glucose-tolerant, and obese type 2 diabetic subjects. Parallel studies of arteriovenous fractional extraction across the leg of [18F]FDG and [2-3H] glucose were performed to measure the "lumped constant" (LC) (i.e., the analog effect) for [18F]FDG to determine whether this value is affected by insulin dose or insulin resistance. The value of the LC was similar across insulin doses and groups. Leg glucose uptake (LGU) also provided a measure of skeletal muscle glucose metabolism independent of PET. [18F]FDG uptake determined by PET imaging strongly correlated with LGU across groups and across insulin doses (r = 0.81, P < 0.001). Likewise, LGU correlated with PET parameters of glucose transport (r = 0.67, P < 0.001) and glucose phosphorylation (r = 0.86, P < 0.001). Glucose transport increased in response to insulin in the lean and obese groups (P < 0.05), but did not increase significantly in the type 2 diabetic group. A dose-responsive pattern of stimulation of glucose phosphorylation was observed in all groups of subjects (P < 0.05); however, glucose phosphorylation was lower in both the obese and type 2 diabetic groups compared with the lean group at the moderate insulin dose (P < 0.05). These findings indicate an important interaction between transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes.
Similar articles
- Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET.
Kelley DE, Williams KV, Price JC. Kelley DE, et al. Am J Physiol. 1999 Aug;277(2):E361-9. doi: 10.1152/ajpendo.1999.277.2.E361. Am J Physiol. 1999. PMID: 10444433 - The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE, Mintun MA, Watkins SC, Simoneau JA, Jadali F, Fredrickson A, Beattie J, Thériault R. Kelley DE, et al. J Clin Invest. 1996 Jun 15;97(12):2705-13. doi: 10.1172/JCI118724. J Clin Invest. 1996. PMID: 8675680 Free PMC article. - Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes.
Williams KV, Bertoldo A, Kinahan P, Cobelli C, Kelley DE. Williams KV, et al. Diabetes. 2003 Jul;52(7):1619-26. doi: 10.2337/diabetes.52.7.1619. Diabetes. 2003. PMID: 12829624 - Assessing skeletal muscle glucose metabolism with positron emission tomography.
Kelley DE, Price JC, Cobelli C. Kelley DE, et al. IUBMB Life. 2001 Dec;52(6):279-84. doi: 10.1080/152165401317291129. IUBMB Life. 2001. PMID: 11895076 Review. - Mechanisms of insulin resistance assessed by dynamic in-vivo positron emission tomography imaging.
Ng JM, Kelley DE, Goodpaster BH. Ng JM, et al. Curr Opin Clin Nutr Metab Care. 2009 Sep;12(5):508-12. doi: 10.1097/MCO.0b013e32832eb59a. Curr Opin Clin Nutr Metab Care. 2009. PMID: 19550312 Review.
Cited by
- Insulin, Muscle Glucose Uptake, and Hexokinase: Revisiting the Road Not Taken.
Wasserman DH. Wasserman DH. Physiology (Bethesda). 2022 May 1;37(3):115-127. doi: 10.1152/physiol.00034.2021. Epub 2021 Nov 15. Physiology (Bethesda). 2022. PMID: 34779282 Free PMC article. Review. - Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity.
Koh HE, van Vliet S, Meyer GA, Laforest R, Gropler RJ, Klein S, Mittendorfer B. Koh HE, et al. Diabetologia. 2021 May;64(5):1158-1168. doi: 10.1007/s00125-021-05383-w. Epub 2021 Jan 29. Diabetologia. 2021. PMID: 33511440 Free PMC article. - Utility of Short-Acting Intravenous Insulin Therapy in Preparation of F-18 Fluorodeoxyglucose Positron Emission Tomography Computed Tomography Scan in Cancer Patients Incidentally Detected with High Blood Glucose Levels on the Day of Test.
Rallapeta RP, Manthri RG, Kalawat T, Sachan A, Lakshmi AY, Hulikal N. Rallapeta RP, et al. Indian J Nucl Med. 2020 Apr-Jun;35(2):110-115. doi: 10.4103/ijnm.IJNM_151_19. Epub 2020 Mar 12. Indian J Nucl Med. 2020. PMID: 32351264 Free PMC article. - FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study.
Bauckneht M, Cossu V, Castellani P, Piccioli P, Orengo AM, Emionite L, Di Giulio F, Donegani MI, Miceli A, Raffa S, Borra A, Capitanio S, Morbelli S, Caviglia G, Bruno S, Ravera S, Maggi D, Sambuceti G, Marini C. Bauckneht M, et al. Mol Metab. 2020 Jan;31:98-108. doi: 10.1016/j.molmet.2019.11.007. Epub 2019 Nov 15. Mol Metab. 2020. PMID: 31918925 Free PMC article. - Does 2-FDG PET Accurately Reflect Quantitative In Vivo Glucose Utilization?
Barrio JR, Huang SC, Satyamurthy N, Scafoglio CS, Yu AS, Alavi A, Krohn KA. Barrio JR, et al. J Nucl Med. 2020 Jun;61(6):931-937. doi: 10.2967/jnumed.119.237446. Epub 2019 Nov 1. J Nucl Med. 2020. PMID: 31676728 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials